KPAC 2025

Jumeirah Hotel, KUWAIT

April 20-21, 2025

View Agenda

Shaping the Future of Healthcare

Dear Valued Guests, Colleagues, and Friends,

Welcome to the Kuwait Pharmaceutical Advancement Conference and Exhibition. It is a privilege to host this gathering of brilliant minds and dedicated professionals committed to advancing the pharmaceutical industry. Our agenda is rich with thought-provoking sessions and discussions aimed at inspiring innovation and fostering collaboration. We are embarking on a transformative journey in healthcare, and together, we can overcome challenges and seize opportunities to shape the future of our industry. I encourage you to participate actively, share your knowledge, and forge meaningful connections that will drive progress. Thank you for joining us on this important journey. Let us make this conference a defining moment in our shared mission to achieve excellence and innovation.

Dr. Ahmad A Taqi

KPAC 2025

Pharmaceutical Innovation Summit: Insights, Workshops, & Exhibitions

Lectures

Gain invaluable insights from leading experts at our curated lectures, designed to inspire, inform, and propel the pharmaceutical industry forward through cutting-edge research and innovative practices.

Workshops

Participate in interactive workshops, where hands-on experiences and collaborative learning provide practical skills and knowledge to navigate the evolving landscape of the pharmaceutical industry.

Pharmaceutical Exhibition

Explore the future of healthcare at the Pharmaceutical Exhibition, where innovation, technology, and industry leaders come together to showcase the latest advancements and solutions in pharmaceuticals.

Speakers

Meet our esteemed speakers, experts in their fields, who will share valuable insights and innovative ideas throughout the conference.

Dr. Afrah AlAdwani

Dr. Afrah is the Head of the Clinical Pharmacy Unit at Jaber AlAhmad Hospital.
She holds a PhD in Clinical Pharmacy from the University of Strathclyde, Institute of Pharmacy and Biomedical Sciences, UK.
She also earned a Postgraduate Certificate in Researcher Professional Development (PG Cert RPD) from the same institution.
In addition to her leadership role, she is an active member of the Breast Cancer Multidisciplinary Team at Jaber AlAhmad Hospital, contributing to patient-centered oncology care.

Dr. Ahmad Salman

Dr. Ahmad Salman is Assistant Professor, Department of Public Health Practice, College of Public Health, Kuwait University
He holds a Ph.D. in Health Sciences from the University of York, UK.
Dr Ahmad is an expert in cardiovascular health and a public health policy advisor, shaping key health strategies in Kuwait.
He has conducted extensive research in: Cardiovascular health, Public health, and Sustainable development
He is a published author in peer-reviewed journals, a frequent international conference presenter, and a recipient of multiple awards for contributions to public health.
His professional memberships include: American Heart Association and European Society of Cardiology

Dr. Anas Hamad

Dr. Anas is currently the Director of the Pharmacy Department at Qatar’s National Center for Cancer Care & Research and Head of the Medication Safety & Quality Center at Hamad Medical Corporation’s Pharmacy Executive Office.
He also holds a position at Qatar University as a Clinical Associate Professor of Clinical Pharmacy & Practice.
In addition, he chairs the Standing Committee on Medication Services at the Qatar Red Crescent Society and serves as the Vice President & Director of the ISPOR Qatar Chapter.
Dr. Anas completed his BSc in Pharmacy at the University of Jordan, followed by an MSc in Clinical Pharmacy, International Practice & Policy from the University of London, and a PhD in Clinical Practice & Medication Use from King’s College London.
He also obtained an Executive Diploma in Health Services Management from GSM London and completed the Executive Leaders Program with Qatar Leadership Centre.
An active researcher, Dr. Anas has several publications and conference presentations.
He serves as an Editorial Board Member at the International Journal of Clinical Pharmacy and as a Review Editor at Frontiers in Oncology.
He is a frequent speaker at both local and international conferences. Additionally, he is a member of HMC’s and QU’s Institutional Review Boards and the MOPH National Clinical Research Review Committee.

Dr. Bashayer AlMarshad

Bashayer Almarshad is a Senior Clinical Pharmacist with over six years of experience in direct patient care.
She currently works at AlFarwaniya Hospital, specializing in Internal Medicine and Nephrology.
She is an active contributor to several key healthcare initiatives, including the DVT Prophylaxis Committee, Antibiotic Stewardship Program, and Continuous Learning Committee.
Her work in DVT protocol development earned recognition with a Local Excellence Award in Kuwait.
She has played a pivotal role in developing evidence-based protocols that have improved medication safety and treatment strategies, including a nationally adopted Vancomycin dosing protocol for dialysis patients.
As Head of the Training Center at AlFarwaniya Hospital, she is responsible for training newly employed clinical pharmacists and mentoring Pharm D students from Kuwait University.
She has delivered numerous lectures and training sessions to healthcare professionals on patient-centered care, updates in internal medicine and nephrology, and the evolving role of clinical pharmacists.
A respected member of the Clinical Pharmacy Development Committee at the Ministry of Health, she actively contributes to shaping national pharmacy policies.
Her research and expertise have led to published work, including her article on the Role of Clinical Pharmacists in Stevens-Johnson Syndrome and multiple clinical practice protocols.

Dr. Donia Albastaki

Dr AlBastaki is the Head of Drug Registration Department and Acting Director of Pharmaceutical and Herbal Medicine Registration and Control Administration, Ministry of Health.
She has a twenty years working experience in the pharmaceutical field; area of expertise are regulatory affairs and pharmacovigilance.
She Contributed to the development of drug regulatory framework and policies in Kuwait and GCC.
She is responsible of registration and approval of a various pharmaceutical and health products, in addition to laboratory analysis of medical products, and monitoring post marketing drugs safety and efficacy.
She has a 17 years’ experience in GMP inspection through which she inspected several international, regional and local pharmaceutical manufacturing companies.
She is a Member of Gulf Health Council Central Drug Registration Committee and contributed to setting the GCC Guidelines for Drug Registration as well as Stability, Bioequivalence and PIL GCC guidelines and others.
She’s a member of the International Society of Pharmacovigilance and Kuwait deputy focal point for Uppsala Monitoring Center /WHO Collaborating Center for International Drug Monitoring.
She was also assigned as Kuwait focal point with the League of Arab states in the field of Pharmacy and drugs and participated in the development of the Arab Bioequivalence Guidelines.

Dr. Eman Abahussain

Dr. Abahussain is a renowned pharmacy educator and healthcare leader with over 25 years of experience in pharmacy practice, education, and public health initiatives.
She currently serves as the Director of Dahia Abdullah Al-Salem Healthy City, where she played a key role in achieving WHO accreditation in 2022.
She holds a PhD in Pharmacy from Cardiff University, with research focusing on dyspeptic patient management and H. pylori infection in Kuwait.
Dr. Abahussain has spent many years shaping pharmacy education as a Senior Clinical Lecturer at Kuwait University, teaching pharmaceutical care, research methods, and ethics.
Beyond academia, she has led national initiatives on medication safety, environmental health, and poisoning prevention, making a significant impact on public health.
She is also a prolific author and researcher, with several books and peer-reviewed publications on pharmacy law, patient safety, and healthcare policies.
Her contributions have been recognized through prestigious awards, including the Sheikh Rashid Bin Hamid Award for her work on medication poisoning in children.
Dr. Abahussain is a sought-after speaker at national and international conferences, sharing insights on pharmaceutical waste management, drug safety, and community health.

Dr. Ghazwa B. Korayem

Dr. Ghazwa B. Korayem works as a Consultant to the General Secretariat at the Saudi Commission for Health Specialties (SCFHS) and Director of the Office of Councils and Committees.
She is also an Associate Professor at Princess Nourah bint Abdulrahman University (PNU) College of Pharmacy, bringing extensive expertise in clinical pharmacy, internal medicine, and healthcare education.
Dr. Korayem earned her Bachelor of Pharmaceutical Sciences from King Saud University and a Doctor of Pharmacy (PharmD) degree from Nova Southeastern University, USA. She completed her PGY-1 and PGY-2 training in internal medicine at the University of Arizona Medical Center and is a Board-Certified Pharmacotherapy Specialist.
Additionally, she holds a master’s degree in healthcare education from Texas A&M University.
Her leadership experience includes serving as Vice Dean (2017) and later Acting Dean of PNU’s College of Pharmacy until 2019. She is also a Consultant Internal Medicine Pharmacist at King Abdullah bin Abdulaziz University Hospital.
At SCFHS, Dr. Korayem plays a key role in healthcare education and professional development, chairing the Internal Medicine Residency Examination Committee and serving on the Saudi Pharmacy Licensing Exam Committee. Her contributions to pharmacy education, clinical practice, and healthcare policy continue to shape the future of the profession in Saudi Arabia.

Dr. Homood Al Sobeai

Dr. Homood Al Sobeai holds the position of Associate Professor and serves as the Vice Dean for Graduate Studies and Scientific Research at the College of Pharmacy, King Saud University.
He obtained his bachelor's degree from the College of Pharmacy, King Saud University, in 2009. Subsequently, he pursued and earned a Ph.D. in pharmaceutical sciences with an emphasis on molecular medicine and pharmacogenomics at Nova Southeastern University, Fort Lauderdale, Florida, USA, in 2017.
Dr. Sobeai's journey embodies a fervent commitment to transforming the graduate program environment and advancing scientific research within the college as he established numerous initiatives to standardize graduate programs in the Pharmacology and Toxicology department, where he served as programs director for three years, many of which have been extrapolated to all graduate programs at the college.
Under Dr. Sobeai's leadership, the vice deanship executed over 50 projects, many of which aimed to improve the quality of graduate programs and establish new programs aligned with the market need and vision 2030.

Dr. Hussain Salem Alshamari.

Dr.Hussain Alshamari, BSc, MD, KBCM is Senior Specialist in Clinical Microbiology
Dr.Alshamari is a graduate of Faculty of Medicine, Arabian Gulf University - Kingdom of Bahrain, and Kuwait Board of Clinical Microbiology (KBCM).
Currently working at Sabah Al-Ahmad Urology Center (SAUC) as a full time clinical microbiologist, and he is the Head of Amtimicrobial Resistace (AMR) unit at Kuwait Center For Disease Prevention & Control ( Kuwait CDC ).
He is the Head of Antimicrobial stewardship program at SAUC, and member of European Society of Clinical Microbiology & Infectious Diseases ( ESCMID ) Study Group for Antimicrobial Stewardship ( ESGAP ).
He also has established Al-Sabah Hospital Antimicrobial Stewardship Program.
In addition, he is Co-Leading a local Working Group on Antimicrobial Lock Therapy (ALT) in Collaboration with Kuwait Pharmaceutical Association (KuPha).
His main interests include Antimicrobial Stewardship Programs, Medical Education, Molecular Testing, Diagnosis and Management of MDR Infections and Sexually Transmitted Diseases.

Dr. Ibrahim Alhomoud

Dr. Ibrahim Alhomoud is an Assistant Professor at the College of Pharmacy, Qassim University, and serves as the Head of the Training Unit.
He earned his Doctor of Pharmacy degree from MCPHS University in Boston, USA, followed by postgraduate training at Virginia Commonwealth University (VCU), where he completed a PGY-1
residency, a PGY-2 residency in Ambulatory Care, and a fellowship specializing in cardiometabolic diseases.
Dr. Alhomoud’s professional interests focus on cardiometabolic conditions, with a
particular emphasis on obesity management.
He has authored several research articles related to obesity and its impact on health outcomes.
His academic and clinical contributions highlight his dedication to advancing the field of cardiometabolic care through research, education, and training.

Dr. Maitham Husain.

Dr. Husain was appointed as director of planning and health development since Feb. 2020 at MOH, Kuwait which oversees the national health projects. He had contributed to the development of health system research unit, health policy unit, and health financing unit at the directorate.
As co-director of KIMS/Royal College Collaborative since 2016, Dr. Husain overseas the collaborative with the Royal College of Physician and Surgeon of Canada in the domains of program review and accreditation, faculty development and examinations to improve the postgraduate medical education in Kuwait.
Dr. Husain is a consultant in pediatric medicine, allergy, and clinical immunology with special interest in stem cell therapy. He had completed his residency training in pediatrics at Children’s Hospital, McMaster University and subspecialized in allergy, immunology, and stem cell therapy at the Hospital for Sick Children’s at the University of Toronto.
Dr. Husain main areas of expertise is quality improvement in postgraduate institution and training programs.
Dr. Husain, worked as a consultant for the National Bureau of Accreditation and Quality of Higher Education in setting the standards of accreditation for basic medical education in Kuwait.
He also a strong advocate of patient safety and quality training in residency education and professional development.
Dr. Husain, worked with the National Accreditation Program for Healthcare at Ministry of Health in collaborative with Accreditation Canada International to improve quality of healthcare delivery via accreditation and standard setting. He is also an Accreditation Canada Internal Surveyor since 2018.
Dr. Husain past experiences included hospital management as director of NBK Children’s hospital from May 2017 to Aug. 2019, and CEO of KACCH & BACCH a non-for-profit organization for child life program in hospitals and pediatric palliative care hospice from Feb. 2020 to May 2023. In addition, Dr. Husain was the director of Quality and Accreditation Affairs at KIMS from March 2013 to March 2021.

Dr. Raj Singh Badhan

Dr. Badhan is an Associate Professor of Pharmacokinetics at Aston University, Birmingham, UK. With over 20 years of experience, he has dedicated his career to advancing pharmacokinetics research and education, focusing on optimizing drug therapies for special populations
Dr. Badhan holds an MPharm (Hons) and a PhD in Pharmacokinetics, complemented by four years of post-doctoral research at the renowned Centre for Applied Pharmacokinetics Research, University of Manchester.
His expertise lies in applying advanced pharmacokinetic modeling to solve complex clinical and pre-clinical challenges, with a strong commitment to improving therapeutic outcomes for vulnerable populations.
Since joining Aston University in 2010, Dr. Badhan has played a pivotal role in pharmacy education as Director of the MSc Pharmacokinetics program and Admissions Lead for the MPharm program.
Dr. Badhan’s research is internationally recognized in precision dosing and virtual clinical trials. His work has influenced drug regimen optimization for pediatric and pregnant patients in low-resource settings and contributed to regulatory drug approvals and the development of age-appropriate formulations.
He is actively involved in professional organizations, including the European Pediatric Formulation Initiative and the Controlled Release Society, and serves on the expert panel of the UK Medicines and Healthcare products Regulatory Agency (MHRA).
Beyond academia, Dr. Badhan fosters collaboration in global health as the founder and convener of the West Midlands Pharmacokinetics Network, a platform dedicated to advancing pharmacokinetics in clinical practice.

Dr. Reem Al-Eessa

Dr. AlEssa completed a PhD Pharmaceutical Regulations, MBA General and Strategic Management, MSc Pharmacovigilance and Pharmacoepidemiolog, and a BSc Pharmacy (Hons)
Her areas of experience are, Drug Regulatory Approval system, Community Pharmacy, GMP, Pharmacovigilance, Pharmacy Inspections, and pharmacy licensing system
Currently she is the Director of Drug Inspection Administration, Commissioned, and Pharmacovigilance Superintendent
Previously she was the Head of Registration Department, Drug registration and release superintendent, and Coordination and development superintendent

Dr. Sarah Almanie

Dr. Sarah Almanie is an Assistant Professor at Kuwait University since 2018, specializing in pharmacoeconomics.
She holds a PhD and Master’s degree in Pharmacoeconomics from Virginia Commonwealth University (VCU).
She earned a Bachelor’s degree in Pharmaceutical Sciences from Kuwait University.
Her areas of expertise include:
- Health outcomes research
- Healthcare policy development
- Cost analysis
- Value-based healthcare systems
Dr Sarah is a dedicated to facilitating discussions on healthcare efficiency, policy, and patient-centered care through both teaching and research.

Dr. Sarah AlSharqawi

Sarah Alsharqawi is a Clinical Pharmacist specializing in Intensive Care Units (ICU) at Mubarak Al-Kabeer Hospital in Kuwait.
She earned her Bachelor of Pharmacy (BPharm) in 2016 and subsequently obtained her Doctor of Pharmacy (PharmD) in 2018, as part of the inaugural PharmD cohort in Kuwait.
With a strong focus on infectious diseases and critical illness management, she plays an integral role in multidisciplinary ICU rounds, contributing her expertise to optimize pharmacotherapy and improve patient outcomes.
She has been instrumental in developing multiple ICU protocols and is an active member of the Antimicrobial Stewardship Committee, where she contributed to the creation of an antimicrobial guide to enhance antibiotic stewardship.
Sarah is a regular speaker at scientific meetings, presenting on key topics in critical care pharmacy and antimicrobial optimization.
Since 2021, she has served as a preceptor for PharmD students at Kuwait University, mentoring and training the next generation of clinical pharmacists.

Josephine Falade

Josephine is an Associate Professor and a registered UK pharmacist, with extensive experience across a wide range of pharmacy settings.
She has worked in some of London’s most renowned teaching hospitals, including Barts Health, Guy’s & St Thomas’ Hospital, and Great Ormond Street Hospital for Children, as well as within a Clinical Commissioning Group/Integrated Care Board.
Her clinical focus is in diabetes and endocrinology, and she previously served as a Highly Specialist Pharmacist for Diabetes, Metabolism, and Endocrinology at Barts and The London NHS Trust.
Josephine’s journey with the UCL School of Pharmacy began in 2007 as a Clinical Placement Tutor and became a full-time member of staff in 2016.
She has held several leadership roles at UCL, including:
- Lead Pharmacist for Clinical Trials, Research and Development, Medicines Information, and Education and Training
- Programme Lead for the MSc Clinical Pharmacy, International Practice and Policy since 2018
- Creator of the extended version of this program: MSc Clinical Pharmacy, International Practice and Policy with Extended Placement
Josephine is passionate about advancing global clinical pharmacy practice by empowering pharmacists with the clinical and leadership skills needed to create meaningful change.

Ph. Abdulmohsin Marghalani

Abdulmohsin graduated from Australia with a Bachelor of Pharmacy in 2010 and later earned a Master’s in Clinical Pharmacy from Strathclyde University, UK.
He further expanded his expertise by obtaining an MBA in 2020 from Prince Mohammad bin Salman College.
His career journey began in retail pharmacy in Australia, before returning to Saudi Arabia to join the private sector and later King Abdullah Medical City in 2012, where he led the Outpatient Pharmacy until 2016.
He then took on the role of Director of Pharmacy at Security Forces Hospital, Makkah, before moving to King Faisal Specialist Hospital & Research Centre (KFSH&RC) Jeddah in 2018, where he became Director of Pharmacy in 2020.
Abdulmohsin has also completed a Diploma in Pharmacy Leadership Academy by the ASHP Foundation.
His passion extends beyond pharmacy management to entrepreneurship and mobile health (mHealth) innovation.

Ph. Adel Alsalem

Adel holds a Bachelor of Pharmacy from Liverpool John Moores University, UK, earned in 1997.
He is also certified as a Health Care Accreditation Professional (Surveyor) by Accreditation Canada, underscoring his strong commitment to healthcare quality and standards.
His professional journey began at Farwaniya Hospital Pharmacy (1997–1998) and continued in the TPN unit until 2004.
From 2004 to 2011, he served as Head of the Pharmaceutical Services Department in the Farwaniya Health Region, and then held the same position in the Jahra Health Region (2011–2018).
He later became Director of the Drugs Inspection Administration (2018–2021) and Director of the Central Medical Store (2021–2023).
Currently, Adel serves as the Director of the Pharmaceutical Services Administration, where he leads national efforts to enhance pharmaceutical care and system-wide operations.

Ph. Aisha Alomran

Ph. Aisha graduated from the Faculty of Pharmacy, Kuwait University (2006).
She holds a High Diploma in Health Management and Quality, shifting her career from technical pharmacy roles to managerial leadership.
She had seven years of experience in governmental polyclinics and general hospital pharmacies.
She later on transitioned to the private sector in 2013, gaining expertise in:
- Community pharmacy management (retail & cooperative).
- Tendering, market access, and sales in the pharmaceutical & medical equipment industries.
Currently, with 12 years of private sector experience, she is a key professional in a well-established, fast-growing medical company, contributing to healthcare innovation and accessibility.

Ph.Sara Albalushi

Sara AlBalushi is the Director of the Pharmaceutical Care Directorate at the Directorate General of Medical Supplies, Ministry of Health – Oman.
She graduated from the University of Strathclyde, School of Pharmacy in 1999, and later obtained her Master’s degree in 2009 from the UK.
With over 25 years of experience in the Ministry of Health, Sara has served in various leadership roles, currently overseeing pharmaceutical care services at the national level.
Among her key accomplishments:
- Developed national strategies for pharmaceutical care departments across all levels of healthcare.
- Established policies and procedures standardizing pharmaceutical care in tertiary, secondary, and primary care settings.
- Led efforts to align pharmacy practice with Joint Commission International (JCI) and American Society of Health-System Pharmacists (ASHP) standards.
- Implemented medication safety tools and techniques in collaboration with hospital-based safety officers to reduce medication errors.
- Provides professional development and career guidance for pharmacists under the national pharmaceutical care program.
Currently, Sara is in the final year of her PhD, specializing in polypharmacy management and organizational change.

Prof. Amer M. Alanazi

Professor Amer graduated from the U.S. with a Ph.D. in Pharmaceutical Biotechnology in 2010.
He currently serves as Dean of the College of Pharmacy at King Saud University (KSU) and as a Consultant for the Saudi Council for Health Insurance (CCHI).
He has over 20 years of experience in:
- Pharmaceutical R&D and innovation
- Pharmaceutical technical operations
- Business and market development
- Pharmaceutical logistics and supply chain management
His former roles:
- Biotechnology Consultant for Riyadh Valley Company (2012).
- Vice President of Technical Operations at Tabuk Pharmaceuticals (2015–2018).
- Managing Director for the MENA region at KYBORA Emerging Markets, a U.S.-based healthcare firm.
Amer has successfully executed numerous projects in manufacturing companies, consultancy firms, and training academies.
He is a certified Trainer at the Saudi Digital Library (SDL) and a frequent speaker, delivering lectures and workshops at local, regional, and international conferences.
His Leadership & Consultancy Roles:
- Headed the Risk Management Team at KSU.
- Consultant for the Saudi Electronic University, assisting in curriculum and human resource development.
- Consultant for the Vice-Rectorate of Graduate Studies and Scientific Research, overseeing Riyadh Techno Valley (RTV) projects.
- Vice-Chairman of the Saudi Scientific Society of Pharmaceutical Industries.
Committee Memberships:
- Formulary Governance Committee, Saudi Council for Health Insurance.
- Pharmaceutical Manufacturing Plants & Medicines Registration Committee, Saudi Food and Drug Authority (SFDA).
He published over 140 peer-reviewed articles across various fields of Pharmaceutical Sciences.
Currently enrolled in the Researchers Supporting Project Program and the Distinguished Scientists Fellowship Program at KSU, collaborating with top scientists worldwide.

Prof. Maitham Khajah

Prof. Maitham Khajah is the Acting Dean of the College of Pharmacy at Kuwait University.
He earned his B.Pharm from Kuwait University (2003) and a Ph.D. in Gastrointestinal Science & Immunology from the University of Calgary (2009).
His research focuses on novel molecular targets for inflammatory bowel disease and endocrine resistance in breast cancer.
He has published over 34 peer-reviewed manuscripts, three book chapters, and edited two books.
Prof. Khajah has supervised numerous M.Sc. students and secured multiple research grants as PI and Co-I.
His achievements include the Best Young Researcher Award (2013–2014) and the Jaber Al-Ahmad Young Researchers Award (2019–2020).
He previously served as Head of Pharmacology and Therapeutics (2018–2022) and was promoted to Full Professor in 2022.

Dr. Ahmad El Ouweini

Ahmad El Ouweini is currently serving as a clinical lecturer in Gulf Medical University, Ajman, UAE. He is also a critical care clinical pharmacist and preceptor at Thumbay University Hospital, the affiliated university hospital with Gulf Medical University.
Recently, Dr. Ahmad completed ACCP-Accredited Post-doctoral Fellowship program in Clinical Pharmacy Research with Critical Care Specialty, a 2-years joint program between Gulf Medical University and Washington State University.
In addition, Ahmad is An American Board-Certified Pharmacotherapy Specialist.
From August 2020 to August 2021, Ahmad worked as a clinical pharmacist (focusing Internal Medicine and Cardiology) in the Lebanese American University (LAU) Medical Center - Rizk Hospital. He was also a clinical lecturer and preceptor at LAU School of Pharmacy.
Ahmad completed his Doctor of Pharmacy Degree in 2019, followed by ASH-Accredited PGY1 Pharmacy residency in 2020 at the Lebanese American University (LAU) School of Pharmacy and Lebanese American University Medical Center Rizk Hospital.
Prior to joining the LAU School of Pharmacy in 2014, Ahmad practiced as an inpatient hospital pharmacist at Dr Sulaiman Al Habib Hospital in Saudi Arabia. Ahmad is currently serving as the Chair of IVPN-AR organizing committee and Leader of IVPN-Critical Care Listserv.

Dr. Bashayr Alsuwayni

Dr. Bashayr Alsuwayni is a consultant pharmacist in ambulatory care and the program director of ambulatory care pharmacy residency in King Saud University Medical City.
She’s a Saudi and American Board-Certified Ambulatory Care Pharmacist, American Board-Certified Pharmacotherapy Specialist, and Certified Diabetic Educator.
She’s passionate about volunteering work. She was one of the Saudi volunteering team organized by King Salman Humanitarian Aid and Relief Center volunteering in healthcare in Za’atri Refugee Camp for Syrian refugee. In addition, she’s coordinating the KSUMC Pharmacy Volunteering Program.
She’s interested in management of chronic diseases, preventative medicine, and mental health and their researches.

Dr. Emad Alsarraf

Dr. Emad Alsarraf is an Assistant Professor in the Department of Pharmacy Practice at Kuwait University and a practicing clinical pharmacist in the Emergency Department at Mubarak Al-Kabeer Hospital.
Dr. Alsarraf earned his Doctor of Pharmacy (PharmD) degree from Massachusetts College of Pharmacy and Health Sciences (MCPHS) University, Worcester, USA, in 2017. He then pursued extensive post-graduate training, completing a PGY-1 residency, a PGY-2 in emergency medicine, and a clinical fellowship at Brigham and Women’s Hospital in Boston.
He is a Board-Certified Pharmacotherapy Specialist (BCPS) and a Board-Certified Emergency Medicine Pharmacist (BCEMP).
His favorite drug? Sodium Nitroprusside

Dr. Khalid Ahmad Sheikh

Dr. Sheikh holds a PhD in Pharmaceutics from the University of Strathclyde, Glasgow, an MSc in Pharmaceutics from University Science Malaysia, and a Bachelor of Pharmacy from the University of the Punjab, Pakistan.
He is also recognized as a Senior Fellow of the Higher Education Academy (SFHEA) in the UK.
Dr. Sheikh’s career spans over two decades, beginning in industry as a Production Manager and QA/Regulatory Affairs Pharmacist in Malaysia, followed by nearly a decade in academia at the International Medical University, Malaysia.
Since 2010, he has been part of the UCL School of Pharmacy, where he currently serves as an Associate Professor in the Department of Pharmaceutics.
His academic roles include:
- Director of the Qualified Person (QP) Course at UCL
- Course Director for the Postgraduate Diploma in Pharmaceutical Quality and Regulation
- Member of the UCL Clinical Trials Unit Quality Review Group
Dr. Sheikh is also an external examiner for postgraduate programs at multiple institutions, including the University of Strathclyde, Liverpool School of Tropical Medicine, and De Montfort University.
He serves on the executive board of the Pharmaceutical and Healthcare Sciences Society (PHSS), contributing to national and international regulatory dialogues.
Over the last 12 years, Dr. Sheikh has delivered specialized training courses in regulatory affairs and quality assurance across the globe, including engagements with:
- The European Medicines Agency (EMA)
- Saudi FDA, Jordan FDA, and Pakistan Pharmaceutical Manufacturers Association (PPMA)
- Pharma industries in Germany, Malta, and the UAE
- Upcoming collaboration with the World Bank to train SFDA Innovation Office Quality Assessors in 2025

Dr. Maha Alharbi

Dr. Maha Alharbi is an Assistant Professor at the College of Pharmacy, Kuwait University.
She holds a BPharm from Kuwait University, an MSc in Clinical Pharmacy from University College London, and a PharmD from MCPHS University.
Her training includes a PGY1 Pharmacy Residency at St. Elizabeth's Medical Center, a Quality and Safety Fellowship at Brigham and Women's Hospital, and a Clinical Research Fellowship at MCPHS University in Boston, MA.
Dr. Alharbi is a Board-Certified Pharmacotherapy Specialist and a Certified Professional in Patient Safety.

Dr. Mona Alenezi

Mona Alenezi is a pharmacist at Al Jahra Hospital and a Ph.D. researcher at Aston University, UK, specializing in clinical pharmacokinetics and personalized medicine.
With expertise in advanced pharmacokinetic modeling and virtual clinical trials, her research focuses on optimizing medication strategies for special populations, including pregnant women and the elderly.
Holding an MSc in Pharmacokinetics from Aston University and a BPharm from King Saud University, Mona is dedicated to translating scientific advancements into real-world healthcare solutions.
Her groundbreaking work in physiologically based pharmacokinetic (PBPK) modeling is shaping the future of precision medicine by improving drug therapy safety and effectiveness for vulnerable patients.

Dr. Raj Singh Badhan

Dr. Badhan is an Associate Professor of Pharmacokinetics at Aston University, Birmingham, UK. With over 20 years of experience, he has dedicated his career to advancing pharmacokinetics research and education, focusing on optimizing drug therapies for special populations
Dr. Badhan holds an MPharm (Hons) and a PhD in Pharmacokinetics, complemented by four years of post-doctoral research at the renowned Centre for Applied Pharmacokinetics Research, University of Manchester.
His expertise lies in applying advanced pharmacokinetic modeling to solve complex clinical and pre-clinical challenges, with a strong commitment to improving therapeutic outcomes for vulnerable populations.
Since joining Aston University in 2010, Dr. Badhan has played a pivotal role in pharmacy education as Director of the MSc Pharmacokinetics program and Admissions Lead for the MPharm program.
Dr. Badhan’s research is internationally recognized in precision dosing and virtual clinical trials. His work has influenced drug regimen optimization for pediatric and pregnant patients in low-resource settings and contributed to regulatory drug approvals and the development of age-appropriate formulations.
He is actively involved in professional organizations, including the European Pediatric Formulation Initiative and the Controlled Release Society, and serves on the expert panel of the UK Medicines and Healthcare products Regulatory Agency (MHRA).
Beyond academia, Dr. Badhan fosters collaboration in global health as the founder and convener of the West Midlands Pharmacokinetics Network, a platform dedicated to advancing pharmacokinetics in clinical practice.

Ph. Bader Kharaibet

Bader Kharaibet is a Senior Pharmacist specializing in Regulatory Affairs.
He has over seven years of experience at the Ministry of Health, Kuwait, as a pharmaceutical products reviewer and Good Manufacturing Practice (GMP) inspector.
He also served as a reviewer and GMP inspector at the Gulf Health Council (GHC).
He holds a BPharm from RCSI and an MSc in Industrial Pharmaceutics from QUB.
He is a Certified Medical Devices Quality Management Systems Auditor (ISO 13485:2016).
He has contributed to pharmaceutical research with a book chapter in Microfluidics in Pharmaceutical Sciences.
His interests include quality, regulatory affairs, and drug delivery.

Dr. Asma Alturkait

Dr. Asma graduated from Kuwait University with a Bachelor’s degree in Pharmacy in 2009 and later pursued an MSc in Clinical Pharmacy from UCL in 2014.
She then earned a PhD in Pediatric Clinical Pharmacology from the University of Nottingham in 2021.
She has been a pharmacist with the Ministry of Health, Kuwait, since 2009, bringing extensive experience in clinical pharmacy and pharmaceutical care.
From 2021 to 2024, she served as a postdoctoral fellow at Dasman Diabetes Institute, focusing on diabetes education and clinical care research. During her time there, she led the WICKED program, an initiative designed to help adolescents with type 1 diabetes manage their condition through insulin, carbohydrate intake, ketone monitoring, and exercise.
Currently, Dr. Asma leads the Clinical Pharmacy Unit at Al-Sabah Hospital, Kuwait, a department established in June 2022

Dr. Dalal M. Al-Taweel

Dr. Dalal Al-Taweel, Ph.D., is an academic pharmacist with a special interest in pharmacy education, pharmaceutical care, and the rational use of medicines.
Dr Al-Taweel is currently an Associate professor at the department of Pharmacy Practice, College of Pharmacy in Kuwait University.
She has held the position of Vice dean of Academic and Student affairs from 2019-2023 where she co-led the transformation of the pharmacy program at the faculty to a PharmD program.
She gained her MPharm degree from Robert Gordon University, Aberdeen, Scotland and her MSc in Clinical Pharmacy as well as a PhD (Pharmaceutical care) from the University of Strathclyde, Glasgow.
Dr Al-Taweel was granted the International Federation of pharmacy’s (FIP) Rising star award in 2022 for her role in enhancing pharmacy education in Kuwait.
She has authored several peer-reviewed articles on quality improvement and performance reporting in health care as well as in pharmacy education, and has co-authored a chapter in the Encyclopedia of Pharmacy Practice and Clinical Pharmacy on a Step-wise approach to competency-based pharmacy education.

Dr. Ethar Makhseed

Dr. Ethar Makhseed is a clinical pharmacist specializing in critical care and an Assistant Professor at Kuwait University's School of Pharmacy.
She earned her MPharm from Keele University (UK) and her PharmD from MCPHS University (USA).
Dr. Ethar further advanced her training by completing an ASHP-accredited PGY1 residency at Norwood Steward Hospital, followed by a two year critical care fellowship at MCPHS University in Boston.

Dr. Munirah Burezq

Dr. Munirah earned her Doctor of Pharmacy (PharmD) degree from Kuwait University in 2018, after completing her Bachelor’s in Pharmacy in 2016.
She has been working as a CCU Clinical Pharmacist at Farwaniya Hospital since 2018, specializing in cardiology critical care.
In addition to her clinical role, she has been a preceptor for the KU-PharmD program in Cardiology Critical Care since 2020, mentoring and training future clinical pharmacists.
She currently leads the Clinical Pharmacy Unit at Farwaniya Hospital

Dr.Bader Alkhurainej

Bader is a Clinical Pharmacist at Mubarak Al-Kabeer Hospital in Kuwait.
He earned his Doctor of Pharmacy (PharmD) in 2022, following a Bachelor of Pharmacy (BPharm) in 2019, both from Kuwait University. He is currently pursuing a Master of Public Health (MPH) at Kuwait University, expected in 2025.
His professional journey began in 2019, with experience as a pharmacist at Jaber Al-Ahmad and Mubarak Al-Kabeer Hospitals, before transitioning into his current clinical pharmacist role in 2023.
In addition to his clinical role, Bader is actively engaged in professional development and leadership:
- Board Member of the Kuwait Pharmaceutical Association (2024–2026)
- Member of the Kuwait Pharmaceutical Advancement Conference & Exhibition (KPAC) Public Relations & Hospitality Committee (2023–2024)
- Former Member of the Scientific and Cultural Committee at KUPHA (2022–2024)
- Former Board Member of the Kuwait Pharmacy Students’ Society (2018–2019)

Ph. Fatemah Alsalman

Ph. Fatemah earned a Bachelor’s in Pharmacy from RCSI and completed an MSc in Pharmaceutical Sciences from RCSI.
She’s a specialized researcher in drug compatibility and use in the NICU setting.
Her Professional Experience:
- Started her career in the Pharmaceutical Department at the Kuwait Food and Drug Administration.
- Currently serves as the Head of the Pharmaceutical Section.

Teamwork

Meet our dedicated team of healthcare and pharmaceutical experts, committed to driving innovation and collaboration through a transformative industry event.

Ahmad Taqi

Chairman

Farah Alenezi

Co-Chairperson

Faisal Alenezi

Head of Scientific Committee

Sharifa Alfajri

Head of Scientific Committee

Bader Alkhurainej

Head of Public Relations & Hospitality Committee

Mohammad Dashti

Head of Technical Committee

Munefa Safar

Head of Volunteer and Marketing Committee

Hassan Alrumaidh

Head of Media Committee

Ansam Marafi

Head of EMT Committee

Amna Alshammari

Head of Organizing Committee

Abdullah Alenzi

Head of Exhibition Committee

Asmaa Alhaqaan

Head of Poster Committee

Frequently Asked Questions

Have questions? Find answers to our most commonly asked questions below

How can I register for the conference?

You can register online by visiting our official website and completing the registration form. Early bird discounts are available.

Are there any workshops or special sessions during the conference?

Yes, the conference will feature specialized workshops and interactive sessions led by industry experts. Details about the workshops, including topics, schedules, and registration requirements, can be found on the official website

Will there be certificates provided for attendees?

Yes, all registered participants will receive a Certificate of Attendance at the conclusion of the conference.

KPAC Policy

## Privacy Policy for KPAC 2025

- Introduction
Welcome to KPAC! Your privacy is important to us, and we are committed to protecting the personal information you share with us. This Privacy Policy explains how we collect, use, disclose, and safeguard your data when you visit our website (the “Website”).

By accessing or using our Website, you agree to the terms outlined in this Privacy Policy. If you do not agree, please refrain from using our services.

- Information We Collect
We may collect the following types of information:

1. Personal Information
Information you provide directly when registering, contacting us, or subscribing to services, such as:
- Name
- Email address
- Phone number
- Payment details (for transactional purposes)

2. Non-Personal Information
Automatically collected data when you access the Website, including:
- Browser type
- IP address
- Operating system
- Pages visited and time spent
- Referring website URLs

3. Cookies and Tracking Technologies
- We use cookies to enhance your browsing experience and collect analytics data. You can manage your cookie preferences through your browser settings.

- How We Use Your Information
We use the information we collect for the following purposes:
- To provide and manage our services.
- To process payments and transactions securely.
- To send promotional emails, updates, or newsletters (with your consent).
- To analyze website performance and improve user experience.
- To comply with legal obligations.

- How We Share Your Information
We do not sell or rent your personal information. However, we may share your data in the following cases:
- With Service Providers: To facilitate payment processing, hosting, or analytics services.
- For Legal Compliance: If required by law or to protect our rights.
- Business Transfers: In case of a merger, sale, or acquisition.

- Data Security
We implement industry-standard measures to protect your information. However, no method of transmission over the internet is 100% secure. We encourage you to take precautions when sharing your information online.

- Your Rights
Depending on your location, you may have the following rights:
- Access, update, or delete your personal data.
- Opt-out of receiving marketing communications.
- Request a copy of the data we hold about you.

To exercise these rights, please contact us.

- Third-Party Links
Our Website may contain links to third-party websites. We are not responsible for the privacy practices of these websites. We recommend reviewing their policies before providing personal information.

- Children's Privacy
Our Website is not intended for individuals under the age of 13, and we do not knowingly collect information from children. If you believe a child has provided personal data, please contact us to delete it.

- Changes to This Policy
We may update this Privacy Policy from time to time. Changes will be reflected on this page with an updated “Effective Date.” We encourage you to review this Policy periodically.

- Contact Us
If you have questions or concerns about this Privacy Policy, please contact us.